Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin W Collie

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
ACS Medicinal Chemistry Letters|July 17, 2024
Fragment-Based Discovery of Novel MUS81 InhibitorsGavin W Collie, Ulf Börjesson, Yunhua Chen, et al.
ACS Chemical Biology|May 28, 2026
Correction to "Targeting the Interaction of NRF2 and β-TrCP with Molecular Glues"Daniel H O Donovan, Jon Winter-Holt, Gavin W Collie, et al.
ACS Chemical Biology|March 30, 2026
Targeting the Interaction of NRF2 and β-TrCP with Molecular GluesDaniel H O Donovan, Jon Winter-Holt, Gavin W Collie, et al.
Journal of Medicinal Chemistry|November 6, 2025
Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2'-Deoxynucleoside 5'-Monophosphate Glycosidase (DNPH1)Bernard Barlaam, Luz Alonso-Crisostomo, Niall A Anderson, et al.
Journal of Medicinal Chemistry|June 3, 2022
Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 InhibitorsOwen A Davis, Kwai-Ming J Cheung, Alfie Brennan, et al.
Journal of Medicinal Chemistry|November 3, 2025
Use of Direct-to-Biology Strategies for the Discovery of 2'-Deoxynucleoside 5'-Monophosphate N-Glycosidase (DNPH1) PROTACsNiall A Anderson, Bernard Barlaam, Argyrides Argyrou, et al.
Journal of Medicinal Chemistry|June 21, 2023
Discovery and Optimization of the First ATP Competitive Type-III c-MET InhibitorIacovos N Michaelides, Gavin W Collie, Ulf Börjesson, et al.
Journal of Medicinal Chemistry|November 30, 2021
Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated PocketMatthew G Lloyd, Rosemary Huckvale, Kwai-Ming J Cheung, et al.
Journal of Medicinal Chemistry|April 11, 2020
Achieving <i>In Vivo</i> Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 DegradersBenjamin R Bellenie, Kwai-Ming J Cheung, Ana Varela, et al.
Scientific Reports|November 4, 2022
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assaysOlivier A Pierrat, Manjuan Liu, Gavin W Collie, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
ACS Medicinal Chemistry Letters|July 17, 2024
Fragment-Based Discovery of Novel MUS81 InhibitorsGavin W Collie, Ulf Börjesson, Yunhua Chen, et al.
ACS Chemical Biology|May 28, 2026
Correction to "Targeting the Interaction of NRF2 and β-TrCP with Molecular Glues"Daniel H O Donovan, Jon Winter-Holt, Gavin W Collie, et al.
ACS Chemical Biology|March 30, 2026
Targeting the Interaction of NRF2 and β-TrCP with Molecular GluesDaniel H O Donovan, Jon Winter-Holt, Gavin W Collie, et al.
Journal of Medicinal Chemistry|November 6, 2025
Discovery and Optimization of a Non-Nucleoside-Based Series of Inhibitors of 2'-Deoxynucleoside 5'-Monophosphate Glycosidase (DNPH1)Bernard Barlaam, Luz Alonso-Crisostomo, Niall A Anderson, et al.
Journal of Medicinal Chemistry|June 3, 2022
Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 InhibitorsOwen A Davis, Kwai-Ming J Cheung, Alfie Brennan, et al.
Journal of Medicinal Chemistry|November 3, 2025
Use of Direct-to-Biology Strategies for the Discovery of 2'-Deoxynucleoside 5'-Monophosphate N-Glycosidase (DNPH1) PROTACsNiall A Anderson, Bernard Barlaam, Argyrides Argyrou, et al.
Journal of Medicinal Chemistry|June 21, 2023
Discovery and Optimization of the First ATP Competitive Type-III c-MET InhibitorIacovos N Michaelides, Gavin W Collie, Ulf Börjesson, et al.
Journal of Medicinal Chemistry|November 30, 2021
Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated PocketMatthew G Lloyd, Rosemary Huckvale, Kwai-Ming J Cheung, et al.
Journal of Medicinal Chemistry|April 11, 2020
Achieving <i>In Vivo</i> Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 DegradersBenjamin R Bellenie, Kwai-Ming J Cheung, Ana Varela, et al.
Scientific Reports|November 4, 2022
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assaysOlivier A Pierrat, Manjuan Liu, Gavin W Collie, et al.
Pageof 6